Diabetes Metab J > Volume 45(6); 2021 > Article
Diabetes & Metabolism Journal 2021;45(6):813-839.
DOI: https://doi.org/10.4093/dmj.2021.0177    Published online November 22, 2021.
Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
Sun Joon Moon  , Inha Jung  , Cheol-Young Park 
Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
Correspondence:  Cheol-Young Park, Tel: cydoctor68@gmail.com, 
Received: 30 July 2021   • Accepted: 24 October 2021
*Sun Joon Moon and Inha Jung contributed equally to this study as co-first authors.
Since Banting and Best isolated insulin in the 1920s, dramatic progress has been made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely injection to maintain optimal glycemic control are often challenging for T1DM patients and their families because they require frequent blood glucose checks. In recent years, technological advances in insulin pumps and continuous glucose monitoring systems have created paradigm shifts in T1DM care that are being extended to develop artificial pancreas systems (APSs). Numerous studies that demonstrate the superiority of glycemic control offered by APSs over those offered by conventional treatment are still being published, and rapid commercialization and use in actual practice have already begun. Given this rapid development, keeping up with the latest knowledge in an organized way is confusing for both patients and medical staff. Herein, we explore the history, clinical evidence, and current state of APSs, focusing on various development groups and the commercialization status. We also discuss APS development in groups outside the usual T1DM patients and the administration of adjunct agents, such as amylin analogues, in APSs.
Key Words: Blood glucose self-monitoring, Diabetes mellitus, type 1, Hypoglycemia, Insulin infusion systems, Pancreas, artificial, Wearable electronic devices
METRICS Graph View
  • 0 Crossref
  • 0 Scopus
  • 468 View
  • 44 Download

Sun Joon Moon

Inha Jung

Cheol-Young Park

Related articles

Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2021 by Korean Diabetes Association.

Developed in M2PI

Close layer